Literature DB >> 2005099

Sites of glycation of human and horse liver alcohol dehydrogenase in vivo.

B H Shilton1, D J Walton.   

Abstract

Sites of in vivo glycation of human and horse liver alcohol dehydrogenase were identified by cleavage of the borotritide-treated enzyme with trypsin, followed by gas-phase sequencing of the resulting tritium-labeled glycated peptides. A blank sequencing result, i.e. failure to detect an amino acid phenylthiohydantoin after completion of an Edman degradation cycle, was ascribed to an N-(1-deoxyhexitolyl)lysyl residue, which represented a glycation site on the original enzyme subunit. In human liver alcohol dehydrogenase the sites affected were the epsilon-amino groups of lysines 10, 39, 231, 248, and 325, which were glycated to the relative extents of 10, 5, 75, 5, and 5%, respectively. The site specificity of in vivo glycation of the horse enzyme is similar; 70-75% of it had occurred at lysine 231. A computer image of the crystal structure of horse liver alcohol dehydrogenase was examined. As a result, it was proposed that the high rate of glycation at lysine 231 is due to acid-base catalysis of the Amadori rearrangement by the imidazole group of histidine 348. This hypothesis was supported by showing that imidazole groups were close to sites of glycation in several other proteins.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2005099

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Site specificity of protein glycation.

Authors:  D J Walton; B H Shilton
Journal:  Amino Acids       Date:  1991-06       Impact factor: 3.520

Review 2.  Glycation of antibodies: Modification, methods and potential effects on biological functions.

Authors:  Bingchuan Wei; Kelsey Berning; Cynthia Quan; Yonghua Taylor Zhang
Journal:  MAbs       Date:  2017-03-08       Impact factor: 5.857

Review 3.  Role of complement and complement regulatory proteins in the complications of diabetes.

Authors:  Pamela Ghosh; Rupam Sahoo; Anand Vaidya; Michael Chorev; Jose A Halperin
Journal:  Endocr Rev       Date:  2015-04-10       Impact factor: 19.871

4.  Glycation and inactivation of sorbitol dehydrogenase in normal and diabetic rats.

Authors:  A Hoshi; M Takahashi; J Fujii; T Myint; H Kaneto; K Suzuki; Y Yamasaki; T Kamada; N Taniguchi
Journal:  Biochem J       Date:  1996-08-15       Impact factor: 3.857

5.  A distinctive histidine residue is essential for in vivo glycation-inactivation of human CD59 transgenically expressed in mice erythrocytes: Implications for human diabetes complications.

Authors:  Rupam Sahoo; Pamela Ghosh; Michael Chorev; Jose A Halperin
Journal:  Am J Hematol       Date:  2017-09-08       Impact factor: 10.047

6.  Histone deacetylase 3 antagonizes aspirin-stimulated endothelial nitric oxide production by reversing aspirin-induced lysine acetylation of endothelial nitric oxide synthase.

Authors:  Saet-Byel Jung; Cuk-Seong Kim; Asma Naqvi; Tohru Yamamori; Ilwola Mattagajasingh; Timothy A Hoffman; Marsha P Cole; Ajay Kumar; Jeremy S Dericco; Byeong-Hwa Jeon; Kaikobad Irani
Journal:  Circ Res       Date:  2010-08-12       Impact factor: 17.367

7.  Molecular mechanisms involved in the resistance of fibrin to clot lysis by plasmin in subjects with type 2 diabetes mellitus.

Authors:  E J Dunn; H Philippou; R A S Ariëns; P J Grant
Journal:  Diabetologia       Date:  2006-03-16       Impact factor: 10.122

8.  In-depth comparative characterization of hemoglobin glycation in normal and diabetic bloods by LC-MSMS.

Authors:  Shih-Hao Wang; Tzu-Fan Wang; Chih-Hsing Wu; Shu-Hui Chen
Journal:  J Am Soc Mass Spectrom       Date:  2014-02-28       Impact factor: 3.109

9.  Nonenzymatic glycosylation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity. A model for intracellular glycosylation in diabetes.

Authors:  I Giardino; D Edelstein; M Brownlee
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

10.  Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation.

Authors:  T Inoguchi; R Battan; E Handler; J R Sportsman; W Heath; G L King
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.